Publication:
Results of concurrent chemoradiotherapy (CRT) with low dose weekly gemcitabine (G) in stage III non-small cell lung cancer (NSCLC).

dc.contributor.authorsAbacioglu, U; Yumuk, PF; Caglar, H; Sengoz, M; Turhal, NS
dc.date.accessioned2022-03-12T15:58:43Z
dc.date.accessioned2026-01-11T17:33:07Z
dc.date.available2022-03-12T15:58:43Z
dc.date.issued2004
dc.identifier.doidoiWOS:000223512402758
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/224142
dc.identifier.wosWOS:000223512402758
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleResults of concurrent chemoradiotherapy (CRT) with low dose weekly gemcitabine (G) in stage III non-small cell lung cancer (NSCLC).
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage695S
oaire.citation.issue14
oaire.citation.startPage695S
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume22

Files